A Biogen facility in Cambridge, Massachusetts.Brian Snyder | ReutersBiogen on Tuesday said it expects to cut approximately 1,000 jobs, or about 11% of...
The Food and Drug Administration on Thursday approved the Alzheimer's treatment Leqembi, a pivotal decision that is expected to expand access to the...
